IRIS Accounts Production v24.3.0.553 05331460 director 1.4.23 31.3.24 31.3.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh053314602023-03-31053314602024-03-31053314602023-04-012024-03-31053314602022-03-31053314602022-04-012023-03-31053314602023-03-3105331460ns15:EnglandWales2023-04-012024-03-3105331460ns14:PoundSterling2023-04-012024-03-3105331460ns10:Director12023-04-012024-03-3105331460ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3105331460ns10:SmallEntities2023-04-012024-03-3105331460ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3105331460ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3105331460ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3105331460ns10:AbridgedAccounts2023-04-012024-03-310533146012023-04-012024-03-3105331460ns10:CompanySecretary12023-04-012024-03-3105331460ns10:RegisteredOffice2023-04-012024-03-3105331460ns5:CurrentFinancialInstruments2024-03-3105331460ns5:CurrentFinancialInstruments2023-03-3105331460ns5:ShareCapital2024-03-3105331460ns5:ShareCapital2023-03-3105331460ns5:RetainedEarningsAccumulatedLosses2024-03-3105331460ns5:RetainedEarningsAccumulatedLosses2023-03-3105331460ns5:NetGoodwill2023-04-012024-03-3105331460ns5:FurnitureFittings2023-04-012024-03-31053314601ns10:Director12023-03-31053314601ns10:Director12022-03-31053314601ns10:Director12023-04-012024-03-31053314601ns10:Director12022-04-012023-03-31053314601ns10:Director12024-03-31053314601ns10:Director12023-03-31
REGISTERED NUMBER: 05331460 (England and Wales)












UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

FOR

BOS EYECARE LIMITED

BOS EYECARE LIMITED (REGISTERED NUMBER: 05331460)






CONTENTS OF THE FINANCIAL STATEMENTS
for the year ended 31 March 2024




Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 4


BOS EYECARE LIMITED

COMPANY INFORMATION
for the year ended 31 March 2024







DIRECTOR: Mr M A Patel





SECRETARY: Poundmore Limited





REGISTERED OFFICE: 19-20 Bourne Court
Southend Road
Woodford Green
Essex
IG8 8HD





REGISTERED NUMBER: 05331460 (England and Wales)





ACCOUNTANTS: Raffingers LLP
Chartered Certified Accountants
19-20 Bourne Court
Southend Road
Woodford Green
Essex
IG8 8HD

BOS EYECARE LIMITED (REGISTERED NUMBER: 05331460)

ABRIDGED BALANCE SHEET
31 March 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - 42,000
Tangible assets 5 - 6,144
- 48,144

CURRENT ASSETS
Stocks - 12,494
Debtors 486,467 292,900
Cash at bank 226,421 280,247
712,888 585,641
CREDITORS
Amounts falling due within one year 41,078 50,872
NET CURRENT ASSETS 671,810 534,769
TOTAL ASSETS LESS CURRENT
LIABILITIES

671,810

582,913

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings 671,808 582,911
SHAREHOLDERS' FUNDS 671,810 582,913

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

BOS EYECARE LIMITED (REGISTERED NUMBER: 05331460)

ABRIDGED BALANCE SHEET - continued
31 March 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Income Statement and an abridged Balance Sheet for the year ended 31 March 2024 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 28 January 2025 and were signed by:





Mr M A Patel - Director


BOS EYECARE LIMITED (REGISTERED NUMBER: 05331460)

NOTES TO THE FINANCIAL STATEMENTS
for the year ended 31 March 2024

1. STATUTORY INFORMATION

BOS Eyecare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2019, is being amortised evenly over its estimated useful life of ten years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 20% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Short term debtors and creditors
Short term debtors and creditors with no stated interest rate are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account.

Loans and borrowings
Loans and borrowings are initially recognised at the transaction price including transactions costs. Subsequently, they are measured at amortised cost using the effective interest rate method, less impairment.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 5 (2023 - 4 ) .

BOS EYECARE LIMITED (REGISTERED NUMBER: 05331460)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 March 2024

4. INTANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 April 2023 70,000
Disposals (70,000 )
At 31 March 2024 -
AMORTISATION
At 1 April 2023 28,000
Amortisation for year 7,000
Eliminated on disposal (35,000 )
At 31 March 2024 -
NET BOOK VALUE

At 31 March 2024 -
At 31 March 2023 42,000

5. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 April 2023 15,000
Disposals (15,000 )
At 31 March 2024 -
DEPRECIATION
At 1 April 2023 8,856
Charge for year 1,229
Eliminated on disposal (10,085 )
At 31 March 2024 -
NET BOOK VALUE
At 31 March 2024 -
At 31 March 2023 6,144

BOS EYECARE LIMITED (REGISTERED NUMBER: 05331460)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 March 2024

6. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 March 2024 and 31 March 2023:

2024 2023
£    £   
Mr M A Patel
Balance outstanding at start of year 231,615 141,926
Amounts advanced 162,382 231,615
Amounts repaid (28,100 ) (141,926 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 365,897 231,615

7. RELATED PARTY DISCLOSURES

During the year, rent was paid to the director of £8,000 (2023: £12,000) for the commercial premises occupied by the company.

After the year end, the director has paid back £162,382 (2023: £28,100) to the company against an overdrawn amount.